Mr Yanliang Chu, Chairman of Fontacea, signed Dr Timothy P. Coogan as the Medicine Safety Consultant

Mr Yanliang Chu, chairman of Fontacea, signed Dr Timothy P. Coogan as the Medicine Safety Consultant in USA on Dec 21,2019.

Dr Timothy P. Coogan graduated from the University of the Sciences in Philadelphia majoring in pharmacology and acquired Board certification in Toxicology. He is a member of the American Society of Toxicology and the previous President of the Mid-Atlantic branch. He has been working in drug non-clinical safety research for almost 30 years. His focus has been on building non-clinical safety assessment strategies for small molecule and biologic therapies in order to provide guidance for first clinical drug application and continuing development. Dr Timothy P. Coogan worked in Johnson & Johnson for 26 years. He was the Vice President of Biologics Toxicology and the Global Head of Nonclinical Drug Safety.